Fonte medicine successfully passed the registration of Ambroksol injection in the Ministry of health of Uzbekistan (hereinafter referred to as Uzbekistan). On Aug , 21 2020, the Ministry of health of Uzbekistan officially issued the registration certificate of Ambroksol injection and the certification of relevant standard documents to Fonte medicine.

Thanks to the friendly relationship with the Ministry of health of Ukraine, the overseas employees of our company completed the registration of the product for more than 6 months (the normal registration period is 8-10 months). We are very grateful for the full support of Shandong Qidu Pharmaceutical Co., Ltd. in the process of registration, and actively cooperated in preparing supplementary documents and providing samples and standards. Finally, with the joint efforts of colleagues at home and abroad, our company successfully obtained the registration certificate of Ambroksol injection.

Ambroksol injection is the second of Fonte medicine registered in UZ, but it will never be the last. We firmly believe that with the spirit of steadfast and willing to work, we will gradually open the door to more overseas markets in the future, which is a step further away from Fonte medicine's grand goal of helping national medicine brand to go to the world!